Antibodies

Davis, United States Founded: 1960 • Age: 66 yrs
Immunochemistry products are developed and manufactured for research clients.

About Antibodies

Antibodies is a company based in Davis (United States) founded in 1960. The company has 23 employees. Antibodies offers products and services including Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies. Antibodies operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.

  • Headquarter Davis, United States
  • Employees 23
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website antibodiesinc.com
  • Social LinkedIn X
  • Legal Name Antibodies Inc.
Key Metrics
  • Latest Funding Round
    $497.41K (USD), Grant

    Sep 2008

  • Investors
  • Employee Count
    23

Products & Services of Antibodies

Antibodies offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies.

Primary Antibodies
Research Reagents

Antibodies for detecting specific proteins in experiments

ELISA Kits
Diagnostic Tools

Kits for enzyme-linked immunosorbent assays in research

Custom Antibody Development
Services

Tailored antibody production for scientific applications

Secondary Antibodies
Research Reagents

Antibodies used in detection and amplification processes

Funding Insights of Antibodies

  • Total Rounds 2
  • Last Round Grant β€” $497,409
  • First Round $746,063

    (Sep 2008)

  • Investors Count 1

All 2 funding rounds of Antibodies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2008$497,409Grant––
Sep 2008$746,063Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Antibodies

Antibodies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Antibodies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Antibodies

4 people are tracked at Antibodies (1 in leadership, 3 in team); the tracked headcount is 23.

NameRoleGroup
Will Fry
PresidentLeadership
Jillian Strom
Research Associate IITeam
Kristen Kralovich
Manager, Antibody DevelopmentTeam
Catherine Fletter
Accounting ManagerTeam
Premium access

Complete people profiles for Antibodies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Antibodies

3 dated milestones of Antibodies across 48 years, from founding to its latest funding, stage changes and deals.

  1. Founded Antibodies is founded.
  2. Funding First funding round of $746K.
  3. Funding Latest funding round, Grant, of $497K.

Competitors of Antibodies

Antibodies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
mabtech.com1986Nacka, Sweden––
Antibodies and immunoassay kits are developed for research applications.
ybiologics.com2007Daejeon, South Korea$42.1M–
Developer of antibodies for the treatment of multiple diseases
epitomics.com2001Burlingame, United States$16.21M–
Monoclonal antibody technology and products are developed by Epitomics.
opmbiosciences.com2013Pudong, China$14.42M–
Antibody and vaccine culture media products are developed.
abtis.co.kr2016Suwon-si, South Korea$4.5M–
Technology for antibody-drug conjugation is provided by AbTis.
vectorlabs.com1976Burlingame, United States––
Labeling and detection reagents immunohistochemistry studies and other life science research applications
leinco.com1992St. Louis, United States––
Manufacturer of antibodies, proteins, reagents, and kits for life science research
icosagen.com2005Tartu, Estonia––
Services in custom antibody and protein production are provided.
Premium access

Detailed competitors of Antibodies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Antibodies

The website of Antibodies (antibodiesinc.com) receives about 21K visits a month.

  • Monthly visits
    21K

    ▼ 9% vs previous month

Similar websites

Websites whose visitors overlap most with Antibodies. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sysy.com
100%
55.8K#662,877View details
biotrend.com
biotrend.com
94%
–#4,074,352–
affbiotech.com
affbiotech.com
93%
–#1,549,129–
komabiotech.co.kr
komabiotech.co.kr
93%
–#1,931,229–
3hbiomedical.com
92%
6.1K#3,489,252View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Antibodies

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Antibodies

Premium access

Complete news archive for Antibodies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Antibodies

10 companies that operate in the same segment as Antibodies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Antibodies

Antibodies was founded in 1960 and raised its 1st funding round 48 years after it was founded.

Antibodies is headquartered in Davis, United States. It is registered at Davis, California, United States.

Antibodies has 23 employees.

Antibodies Incorporated was founded in 1960 in Davis, United States, within the biotechnology sector. Antibody-based IVD kits, primary and secondary antibodies, normal sera, immunochemicals, and labeling kits are produced using extensive animal facilities and advanced laboratories. Custom antibody development, scale-up processes, immuno-chemistry services, assay creation, and animal housing are provided to academic and research institutions.

Antibodies's top competitors include Sino Biological, GenScript and Y-Biologics.

Antibodies offers Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies.

Antibodies has 1 investor. Key investors include HHS.

Antibodies operates through Antibodies Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available